Everyday Health on MSN: Biologics for psoriasis: Are dual inhibitors more effective? Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual. Yahoo Finance: LEO Pharma expands its psoriasis portfolio in China with NMPA approval of Enstilar® NMPA approval of Enstilar® in China marks a significant milestone for LEO Pharma, expanding access to a new treatment option for the estimated 6.5 million adults living with plaque psoriasis in the ...

Understanding the Context

LEO Pharma expands its psoriasis portfolio in China with NMPA approval of Enstilar® Everyday Health on MSN: Rotational therapy in psoriasis treatment: What you need to know Learn how rotational therapy for psoriasis has evolved with the advent of safer, more effective biologic therapies. We just recently published our definition, the National Psoriasis Foundation's, definition of remission for psoriasis, and it was on-trea ...